Emerging importance of geographical indications and designations of origin - Authenticating geo-authentic botanicals and implications for phytotherapy

Phytotherapy Research

Volumn 27, Issue 11, 2013, Pages 1581-1587

  Brinckmann, J A ^a  

^a Traditional Medicinals   (United States)

Author keywords

geo authentic; geo herbalism; geographical indication; protected designation of origin; traditional herbal medicinal product; traditional knowledge

Indexed keywords

AGRICULTURE; CHINA; CLINICAL PRACTICE; DRUG DETERMINATION; DRUG ISOLATION; EUROPE; FLOWER; FOOD AND DRUG ADMINISTRATION; FRUIT; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ORIGIN; HEALTH CARE POLICY; HERBAL MEDICINE; HUMAN; INDIA; MATRICARIA; MEDICINAL PLANT; NONHUMAN; PHYTOTHERAPY; REVIEW; SCHISANDRA; STANDARD; UNITED STATES;

GEO-AUTHENTIC; GEO-HERBALISM; GEOGRAPHICAL INDICATION; PROTECTED DESIGNATION OF ORIGIN; TRADITIONAL HERBAL MEDICINAL PRODUCT; TRADITIONAL KNOWLEDGE;

GEOGRAPHY; MEDICINE, TRADITIONAL; PHARMACOPOEIAS AS TOPIC; PHYTOTHERAPY; PLANTS, MEDICINAL;

EID: 84886306478     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4912     Document Type: Review

References (23)

1. Ayurvedic Pharmacopoeia Committee. 1989. The Ayurvedic Pharmacopoeia of India, Part I, Volume I, 1st edn. Ministry of Health and Family Welfare: New Delhi.
2. [AQSIQ] General Administration of Quality Supervision, Inspection and Quarantine. 2009. AQSIQ Announcement No. 146, 2008, on Approving the Implementation of the Geographical Indication Products Protection over Fushun Liao Schisandra. Annex 1: Quality and Technical Requirements of Fushun Liao Schisandra. AQSIQ: Beijing.
3. Brinckmann J,. 2011. Reproducible efficacy and safety depend on reproducible quality: matching the various quality standards that have been established for botanical ingredients with their intended uses in cosmetics, dietary supplements, foods, and medicines. HerbalGram 91: 40-55.
4. Bruni R, Sacchetti G,. 2009. Factors affecting polyphenol biosynthesis in wild and field grown St. John's wort (Hypericum perforatum L. Hypericaceae/Guttiferae). Molecules 14: 682-725.
5. Chinese Pharmacopoeia Commission. 2010. Pharmacopoeia of the People's Republic of China. China Medical Science Press: Beijing.
6. Council of the European Union. 2006. Council Regulation (EC) No 510/2006 of 20 March 2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs. Off J Eur Union 49: L 93/12-25.
7. European Commission. 2007. Publication of an application pursuant to Article 6(2) of Council Regulation (EC) No 510/2006 on the protection of geographical indications and designations of origin for agricultural products and foodstuffs. Off J Eur Union 50: C 243/11-13.
8. European Commission. 2009. Commission Regulation (EC) No 506/2009 of 15 June 2009 entering a designation in the register of traditional specialities guaranteed (Olej rydzowy (TSG)). Off J Eur Union 52: L 151/26.
9. European Commission. 2010. Commission Regulation (EU) No 415/2010 of 12 May 2010 entering a name in the register of protected designations of origin and protected geographical indications (Tettnanger Hopfen (PGI)). Off J Eur Union 53: L 119/5-6.
10. European Commission. 2011. Commission implementing regulation (EU) No 1072/2011 of 20 October 2011 entering a name in the register of protected designations of origin and protected geographical indications (Liquirizia di Calabria (PDO)). Off J Eur Union 54: L 278/1-2.
11. European Commission. 2012. Commission implementing regulation (EU) No 165/2012 of 24 February 2012 entering a name in the register of protected designations of origin and protected geographical indications (Alföldi kamillavirágzat (PDO)). Off J Eur Union 55: L 53/4-9.
12. European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC). 2008. Final Community Herbal Monograph on Humulus lupulus L., flos. European Medicines Agency: London; Doc. Ref. EMEA/HMPC/513617/2006.
13. European Pharmacopoeia Commission. 2011. European Pharmacopoeia 7.0. European Directorate for the Quality of Medicines: Strasbourg.
14. Japanese Pharmacopoeia Commission. 2011. The Japanese Pharmacopoeia, 16th edn. Ministry of Health, Labour and Welfare: Tokyo.
15. Larson J,. 2007. Relevance of geographical indications and designations of origin for the sustainable use of genetic resources. Global Facilitation Unit for Underutilized Species: Rome.
16. Natural Health Products Directorate (NHPD). 2009. Single Ingredient Monographs: German Chamomile. Health Canada: Ottawa.
17. Raustiala K, Munzer SR,. 2007. The global struggle over geographical indications. Eur J Int Law 18: 337-365.
18. [SAIC] Trademark Office of the State Administration for Industry & Commerce of the People's Republic of China. 2011. The AICs at all levels in Yunnan strengthened the guidance and service for certification trademarks of geographical indications and promoted the work of enriching farmers by trademarks. State Administration for Industry & Commerce: Beijing.
19. State Food and Drug Administration (SFDA). 2002. Good Agricultural Practice for Chinese Crude Drugs (Interim). State Food and Drug Administration: Beijing.
20. Shi JY, Yuan XF, Lin HR, Yang YQ, Li ZY,. 2011. Differences in soil properties and bacterial communities between the rhizosphere and bulk soil and among different production areas of the medicinal plant Fritillaria thunbergii. Int J Mol Sci 12: 3770-3785.
21. [USP] United States Pharmacopeial Convention. 2012. United States Pharmacopeia, 35th Revision. United States Pharmacopeial Convention: Rockville.
22. Xiaobing Y, Kireeva I,. 2011. Q&A Manual: China Legislation on Geographical Indications. EU-China Project for the Protection of Intellectual Property Rights (IPR-2): Beijing.
23. Zhou ZZ, Guo P, Brand E,. 2012. The formation of daodi medicinal materials. J Ethnopharmacol 140: 476-481.